Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Blood

• Publication date

  2012-04-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood-2011-11-391383PMID 22289887PMCID PMC3321853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.

  2013cited by this paper
• Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae

  2010cited by this paper
• Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.

  2010cited by this paper
• Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.

  2010cited by this paper
• Recurrent Preeclampsia: The Effect of Weight Change Between Pregnancies

  2010cited by this paper
• SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.

  2010cited by this paper
• Dalteparin for the prevention of recurrence of placental‐mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial

  2009cited by this paper
• Anticoagulants to prevent placenta-mediated pregnancy complications: a review of current evidence

  2009cited by this paper
• Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

  2009cited by this paper
• Thrombophilia and placenta-mediated pregnancy complications: from the bench to bedside to policy.

  2009cited by this paper
• Recurring Complications in Second Pregnancy

  2009cited by this paper
• Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Inherited thrombophilia and pregnancy complications revisited.

  2008cited by this paper
• Erratum: Inherited thrombophilia and pregnancy complications revisited (Obstetrics & Gynecology (2008) 112 (320-324))

  2008cited by this paper
• Randomized Trials Stopped Early for Benefit

  2007cited by this paper
• Recurrence of Ischemic Placental Disease

  2007cited by this paper
• Anticoagulants in Pregnancy

  2006cited by this paper
• Anticoagulants in Pregnancy

  2006cited by this paper
• Pre-eclampsia

  2005cited by this paper
• Low-Molecular-Weight Heparin Lowers the Recurrence Rate of Preeclampsia and Restores the Physiological Vascular Changes in Angiotensin-Converting Enzyme DD Women

  2005cited by this paper
• Randomized trials stopped early for benefit: a systematic review.

  2005cited by this paper
• [Effect of heparin on fetal growth restriction].

  2004cited by this paper
• Thrombophilia and pregnancy complications.

  2004cited by this paper
• Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries.

  2004cited by this paper
• Pre-eclampsia

  2000cited by this paper
• Thrombosis in pregnancy: maternal and fetal issues.

  1999cited by this paper
• Outcome of very preterm small for gestational age infants: the first nine years of life

  1998cited by this paper
• Prevention of pre‐eclampsia in high risk women with renal disease: A prospective randomized trial of heparin and dipyridamole

  1995cited by this paper
• Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis.

  1991cited by this paper
• Parity and Pre‐Eclampsia

  1979cited by this paper
• A multiple testing procedure for clinical trials.

  1979cited by this paper

• Kidney health outcomes of hypertensive disorders of pregnancy

  2025cites this paper
• Recurrent Pregnancy Loss

  2025cites this paper
• Low-Molecular-Weight Heparin in Preeclampsia: Effects on Biomarkers and Prevention: A Narrative Review

  2025cites this paper
• Network meta-analysis: comparative efficacy of diverse aspirin dosages and heparin in mitigating placenta-mediated pregnancy complications

  2025cites this paper
• Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis

  2024cites this paper
• Investigation and Care of a Small‐for‐Gestational‐Age Fetus and a Growth Restricted Fetus (Green‐top Guideline No. 31)

  2024cites this paper
• Use of anticoagulants to improve pregnancy outcomes in couples positive for M2 haplotype: A systematic review.

  2024cites this paper
• Prevention of preeclampsia.

  2024cites this paper
• Interventions, outcomes and outcome measurement instruments in stillbirth care research: A systematic review to inform the development of a core outcome set

  2023cites this paper
• ПРОФІЛАКТИКА ПРЕЕКЛАМПСІЇ: СУЧАСНИЙ СТАН ПРОБЛЕМИ

  2023cites this paper
• Recurrent Pregnancy Loss Etiology, Risk Factors, Diagnosis, and Management. Fresh Look into a Full Box

  2023cites this paper
• Pravastatin in preeclampsia: A meta-analysis and systematic review

  2023cites this paper
• Low molecular weight heparin and pregnancy outcomes in women with inherited thrombophilia: A systematic review and meta‐analysis

  2022cites this paper
• Enoxaparin Increases D6 Receptor Expression and Restores Cytoskeleton Organization in Trophoblast Cells from Preeclampsia

  2022cites this paper
• Pre-Eclampsia and Intrauterine Growth Restriction (IUGR)Prevention– Is Enoxaparin an Effective Option

  2022cites this paper
• Low molecular weight heparin prophylaxis for placenta-mediated complications in women with F2G20210A mutation

  2021cites this paper
• Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registry.

  2021cites this paper
• Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis.

  2021cites this paper
• Recurrence Risk of Fetal Growth Restriction: Management of Subsequent Pregnancies.

  2021cites this paper
• Pharmacological Interventions for the Prevention of Fetal Growth Restriction: A Systematic Review and Network Meta‐Analysis

  2021cites this paper
• Combined Anticoagulant Therapy for Prevention of Preeclampsia and Small for Gestational Age Neonates: A Systematic Review and Meta-analysis

  2021cites this paper
• Gestational Hypertension and Preeclampsia: An Overview of National and International Guidelines

  2021cites this paper
• Low Molecular Weight Heparins (LMWH) and Implications along Pregnancy: a Focus on the Placenta

  2021cites this paper
• Pregnancy outcomes in patients with MTHFR gene polymorphism: A case series

  2020cites this paper
• Factors effective in the prevention of Preeclampsia:A systematic review.

  2020cites this paper
• Prevention of thrombosis

  2020cites this paper
• Effectiveness of the use of Low Molecular Heparin in patients with repetition abortion history: Systematic review and meta-analysis

  2020cites this paper
• Endothelial dysfunction in context of women’s health disorders from menarche to menopause

  2020cites this paper
• Early Prophylactic Enoxaparin for the Prevention of Preeclampsia and Intrauterine Growth Restriction: A Randomized Trial

  2020cites this paper
• Association between prophylactic low‐molecular‐weight heparin use in pregnancy and macrosomia: analysis of the Ottawa and Kingston birth cohort

  2019cites this paper
• The risk of cesarean delivery after labor induction among women with prior pregnancy complications: a subgroup analysis of the AFFIRM study

  2019cites this paper
• Overexpression of lncRNA EPB41L4A-AS1 Induces Metabolic Reprogramming in Trophoblast Cells and Placenta Tissue of Miscarriage

  2019cites this paper
• Comparison of 2 approaches in management of pregnant women with inherited trombophilias

  2019cites this paper
• Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC

  2019cites this paper
• Autophagy is a new protective mechanism against the cytotoxicity of platinum nanoparticles in human trophoblasts

  2019cites this paper
• Thrombophilia in Pregnancy

  2019cites this paper
• Aspirin and heparin for the prevention of pre-eclampsia: protocol for a systematic review and network meta-analysis

  2019cites this paper
• The Role of Low Molecular Weight Heparin in Pregnancies of Patients with Inherited Thrombophilia that Have Presented (and) Thrombotic Complications During Previous Pregnancies

  2018cites this paper
• THROMBOPHILIA AND ITS IMPACT ON PREGNANCY, PREVENTING COMPLICATIONS

  2018cites this paper
• Placental-Fetal Growth Restriction

  2018cites this paper
• Care prior to and during subsequent pregnancies following stillbirth for improving outcomes.

  2018cites this paper
• Prophylaxis and treatment of foetal growth restriction.

  2018cites this paper
• Low molecular weight heparin for the prevention of severe preeclampsia: where next?

  2018cites this paper
• Inherited Thrombophilia and Pregnancy Complications: Should We Test?

  2018cites this paper
• Gerinnungsstörungen der Frau

  2018influential citation
• Prophylaxis for Fetal Growth Restriction: Aspirin and Low-Molecular-Weight Heparins

  2018cites this paper
• Tinzaparin for the treatment of foetal growth retardation: An open-labelled randomized clinical trial.

  2018cites this paper
• Cerebral Palsy—Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and Prevention

  2017cites this paper
• Low–Molecular-Weight Heparin for the Prevention of Placenta-mediated Pregnancy Complications

  2017cites this paper
• The Role of Anticoagulants in the Prevention of Pregnancy Complications

  2017cites this paper
• Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial

  2017cites this paper
• Antiangiogenic effects of decorin restored by unfractionated, low molecular weight, and nonanticoagulant heparins.

  2017cites this paper
• The impact of low molecular weight heparin on obstetric outcomes among unexplained recurrent miscarriages complicated with methylenetetrahydrofolate reductase gene polymorphism.

  2017cites this paper
• The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.

  2017cites this paper
• Thrombophilia and Thrombocytopenia in the Pregnant Woman

  2017cites this paper
• The role of thrombophilia testing in women with adverse pregnancy outcomes

  2017cites this paper
• Primjena antikoagulansa u trudnoći

  2017cites this paper
• Gerinnungsphysiologie bei Totgeburten

  2017cites this paper
• Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial

  2016cites this paper
• Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies

  2016cites this paper
• Aspirin vs Heparin for the Prevention of Preeclampsia

  2016influential citation
• A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia.

  2016cites this paper
• Does low‐molecular‐weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early‐onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results

  2016cites this paper
• Management of inherited thrombophilia in pregnancy

  2016cites this paper
• Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.

  2016cites this paper
• New lenses to look at preeclampsia

  2016cites this paper
• LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia

  2016cites this paper
• Aspirin for the Prevention of Preeclampsia and Intrauterine Growth Restriction.

  2016cites this paper
• Prevention of pre‐eclampsia by low‐molecular‐weight heparin in addition to aspirin: a meta‐analysis

  2016cites this paper
• Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history – an open-label randomised trial (the EPPI trial): study protocol

  2016cites this paper
• Adverse Perinatal Outcome in Subsequent Pregnancy after Stillbirth by Placental Vascular Disorders

  2016cites this paper
• Reproductive Issues in Women with Bleeding and Thrombotic Disorders

  2016cites this paper
• Care prior to and during subsequent pregnancies following stillbirth for improving outcomes

  2016cites this paper
• Management of inherited thrombophilia in pregnancy

  2016cites this paper
• Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome

  2016influential citation
• Activation of Protein C in Human Trophoblasts in Culture and Downregulation of Trophoblast Endothelial Protein C Receptor by TNF-α

  2015cites this paper
• Aspirin and heparin in pregnancy

  2015cites this paper
• LMWH to prevent placenta‐mediated pregnancy complications: an update

  2015cites this paper
• Low molecular weight heparin treatment and impact of inherited thrombophilia type in pregnancies with previous adverse outcome

  2015cites this paper
• Haemodynamics and vascular remodeling in vascular access : insights from numerical studies

  2015cites this paper
• Low molecular weight heparin: does it represent a clinical opportunity for preventing preeclampisa associated with fetal growth restriction?

  2015cites this paper
• Current Theories on the Prevention of Severe Preeclampsia With Low-Molecular Weight Heparin

  2015cites this paper
• Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis.

  2015cites this paper
• Counseling women with hypertensive disorders of pregnancy

  2015cites this paper
• Antithrombotic Treatment for Recurrent Miscarriage

  2015cites this paper
• The physiologic anticoagulant and anti-inflammatory role of heparins and their utility in the prevention of pregnancy complications

  2015cites this paper
• Dalteparin for pregnant women with thrombophilia.

  2015cites this paper
• Low Molecular Weight Heparin Modulates Maternal Immune Response in Pregnant Women and Mice with Thrombophilia

  2015cites this paper
• [Comparing the Application of Hema-Obs RSS to 250 Pregnancies from Obstetrics/Hematology Consultation in Centro Hospitalar São João, Portugal with the Application of Galit Sarig RSS to 90 Pregnancies from Rambam Health Care Campus, Israel].

  2015cites this paper
• SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014

  2015cites this paper
• Coagulation and Placenta-Mediated Complications

  2014cites this paper
• Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.

  2014cites this paper
• Pregnancy and venous thromboembolism: 'TIPPS' for risk stratification.

  2014cites this paper
• Anticoagulation in pregnancy complications.

  2014cites this paper
• Thrombophile Gerinnungsstörung und Antiphospholipidsyndrom

  2014cites this paper
• Challenges in cardiology research in pregnancy.

  2014cites this paper
• Overview of low molecular weight heparin for preventative treatment of adverse obstetric outcomes related to abnormal placentation

  2014cites this paper
• Venous thromboembolism and antithrombotic therapy in pregnancy.

  2014cites this paper
• Recurrent pregnancy loss and thrombophilia.

  2014cites this paper
• Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications.

  2014cites this paper